Cargando…
Methylene Blue has a potent antiviral activity against SARS-CoV-2 and H1N1 influenza virus in the absence of UV-activation in vitro
Methylene blue is an FDA (Food and Drug Administration) and EMA (European Medicines Agency) approved drug with an excellent safety profile. It displays broad-spectrum virucidal activity in the presence of UV light and has been shown to be effective in inactivating various viruses in blood products p...
Autores principales: | Cagno, Valeria, Medaglia, Chiara, Cerny, Andreas, Cerny, Thomas, Zwygart, Arnaud Charles-Antoine, Cerny, Erich, Tapparel, Caroline |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8275569/ https://www.ncbi.nlm.nih.gov/pubmed/34253743 http://dx.doi.org/10.1038/s41598-021-92481-9 |
Ejemplares similares
-
An anti-influenza combined therapy assessed by single cell RNA-sequencing
por: Medaglia, Chiara, et al.
Publicado: (2022) -
Interferon Lambda Delays the Emergence of Influenza Virus Resistance to Oseltamivir
por: Medaglia, Chiara, et al.
Publicado: (2021) -
Antiviral properties of trans-δ-viniferin derivatives against enveloped viruses
por: Zwygart, Arnaud Charles-Antoine, et al.
Publicado: (2023) -
Geneticin shows selective antiviral activity against SARS-CoV-2 by interfering with programmed −1 ribosomal frameshifting
por: Varricchio, Carmine, et al.
Publicado: (2022) -
Geneticin shows selective antiviral activity against SARS-CoV-2 by interfering with programmed −1 ribosomal frameshifting
por: Varricchio, Carmine, et al.
Publicado: (2022)